Get started
AURORA CANNABISAURORA CANNABISAURORA CANNABIS

AURORA CANNABIS

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

21P trade ideas

Sold $5.58 Yesterday for 3% loss. Re-Entering TomorrowRisky swing trade, but I think this reaction is just panic selling from the news yesterday. A lot of people are holding a bag right now, so when the news hit they freaked out. A lot of new traders attracted to weed stocks. It was also hovering around $3.00 before they made all those acquisitions The volume was unspectacular relatively speaking. Funds have already unloaded a lot of stock at this point, which you can see on the two big volume days that happened just recently -- one day for 30 million, the other 20 million. Like the risk reward. I may hold, but if I'm up nicely, I might sell too. Depends on a lot of factors whether I hold. Buying the dip or the open depending on the price action. Will be scaling into my position nonetheless. If it closes strong, I'll fill. No buy half this time, filling the whole thing today
TSX:ACBLong
by alipipefitter
2
ACB see's a dip to $7.92 after announcement about MedReleaf" ACB announces it has received shareholder approval at a special meeting, held today, for the issuance of shares in consideration for the planned acquisition of MedReleaf Corp. ("MedReleaf"), a well-known Canadian Licensed Producer based in Markham, Ontario that delivers premium medical cannabis products to domestic and global markets, and compelling brands to the adult-use recreational market." Dillution, is a fact of company issuing shares for operating expenses, in this case it's a merger. There won't be a dillution, more shares will be issued and capital value of company will increase. So, currently 4.2bln, and it will be 7.6 bln, about the same as Canopy. It's the reason why Canopy is declining, because Aurora is bigger now. Leaders in the industry get higher p/e and share price as result... soon will be back at $9. There's some selling by Medreleaf are going on Aurora side, it's a reason, why we can't push back above 50 days. More Information about the Announcement here: Industry-leading scale: Funded capacity will increase to over 570,000 kg of high-quality cannabis per year, to be delivered through nine facilities in Canada and two in Europe Low production costs and industry-leading yields: Aurora's automated 'Sky Class' greenhouses are expected to deliver industry-leading efficiencies and ultra-low production costs of well below $1 per gram, delivering sustainably robust margins. MedReleaf's high-yield cultivation techniques are expected to further enhance productivity and reduce costs across the combined entity's facilities. International distribution: Aurora has established a strong and rapidly growing footprint in the international medical market. The combined entity is now well-positioned to rapidly gain market share in a number of significant markets. Most notable among these, is the European Union, which will have in excess of 400 million people following Brexit. Expanding brand leadership: Aurora, CanniMed and MedReleaf represent three well-established medical cannabis brands, and a growing portfolio of premium consumer and wellness brands including San Rafael '71, Woodstock, and AltaVie that are backed by detailed consumer and marketplace insights and advanced analytical frameworks. This brand leadership positions the combined entity well to drive accelerated growth through its existing distribution channels for the domestic medical and consumer markets, as well as the international medical markets. Scientific leadership: Each company is actively engaged in clinical trials and medical studies, which has resonated strongly with the international medical community, driving above-average prescription rates and referrals. Further, both companies have developed considerable expertise in cannabis plant genetics, enabling the development of new cultivars with specific traits for a variety of domestic and international markets, as well as strains optimized for automated cultivation. R&D: The combined company will have an industry leading Science and Research & Development team that includes approximately 40 PhDs and MScs. Both companies have a proven track record in developing new products, adopting new technology throughout the value chain, and integrating innovations from third parties. Combining these capabilities will accelerate product development and technology adoption, creating strong, defensible competitive advantages, including, management believes higher-margin offerings to drive above average profitability.
TSX:ACBLong
by zcsniper
3
Knifecatching on AuroraAurora is reaching a nice extension from the previous bullish swing and is currently oversold on multiple smaller timeframes. The Stochastic has already crossed bullish at the bottom and bears are exausted. A minor move to raise the weekly close may be seen today. If not, I will update new targets. The RSI hasn't been low very often this year so a bounce is not unlikely. First resistance tends to be at Kijun (red line). Smaller bullish divergence already on 1 hour TF. May be good for long term positioning. Blue line indicates a bullish confirmation
TSX:ACBLong
by RoyalOakFI
Buy Target Prices After the previous failed uptrendMy last trade failed due to bear pressure I was able to get out at 9.50 for a couple hundred dollars profit. rebought and 9.00 and resold at 9.12 for 1200 dollar day trade. the Bear pressure is huge the shorts have locked up some huge positions recently and with selling pressure we close below the daily 50 Day Moving Average. I think the bears will push it down to break and retest the 200 MA currently sitting at 8.30ish CAD. Monday should be very volatile as current investors see the bear momentum which more selling pressure and larger short positions will come in. we are due for a 200 day MA break since it hasn't happened in over a year. so will they push ACB into the 7's again? most likely but not for long. The buying support will come in and 8.00 will be ACB's major future support. I'm on the sidelines right now waiting for my entry.
TSX:ACB
by derekh42
2
Short ACB - Buy the Rumor, Sell the News.As much as I like the company, the current price is high. This trade is a basic "Buy the rumor, Sell the news" play. I shorted at 9.70 and have an exit zone of EMA 26 Low exit trigger and 8.06 as the target cover price. I will be watching morning volume, price action, and momentum, to confirm exit price. This also applies to my Stop Loss/Break-even zone should this trade reverse sharply on rumors, speculation or news. My logic is that ACB likes to settle in around 8 bucks and change, which is a median zone for this stock. Or in simple terms; I believe the price will swing back to the best fair price the market likes to trade at, the 8.02/8.06 zone. I don't expect a lot of action over the summer while parliament is out for the summer. But one never knows. Trading pots stocks is a bit like "herding cats". They just run in different directions without notice. LOL
TSX:ACBShort
by 4XRandalll
5